Impel NeuroPharma, Inc., is a privately-held, Seattle-based company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases. Impel's products are based on a novel nasal drug delivery platform, the POD™ device, that administers drug to the upper nasal cavity in a consistent and predictable manner.

Pharmaceutical

Impel Pharmaceuticals

Leonard S. Paolillo

Michael Malafronte

Chris Jeffries

Beth Lydin

Rigo Canal

Brett Downing

Karen Bodin-Rincon

Scott Patry

Kelly Fitzgerald

Leadership Team

Sales Team

Advisory and Review Committee

Teams at Impel Pharmaceuticals

Leadership Team

Sales Team

Advisory and Review Committee